BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6174166)

  • 21. [Tumor markers. Current use in antineoplastic strategy].
    Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
    Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
    [No Abstract]   [Full Text] [Related]  

  • 22. The immune system in gynecologic malignancies.
    Barber HR; Dorsett B
    Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of tumour markers.
    Lai LC; Cheong SK; Goh KL; Leong CF; Loh CS; Lopez JB; Nawawi H; Sivanesaratnam V; Subramaniam R;
    Malays J Pathol; 2003 Dec; 25(2):83-105. PubMed ID: 16196365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fetalism of cancer - analysis of enzyme patterns].
    Taniguchi N
    Hokkaido Igaku Zasshi; 1975 Mar; 50(2):249-50. PubMed ID: 53177
    [No Abstract]   [Full Text] [Related]  

  • 26. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
    Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological markers as prognostic and clinical evaluation tools.
    Tormey DC; Waalkes TP
    Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
    [No Abstract]   [Full Text] [Related]  

  • 28. Historical development and potential uses of tumor antigens as markers of human cancer growth.
    Gold P; Shuster J
    Cancer Res; 1980 Aug; 40(8 Pt 2):2973-6. PubMed ID: 6249494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke].
    Snit M
    Med Pr; 1993; 44(1):21-8. PubMed ID: 7684110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Present and future clinical relevance of tumour markers.
    Franchimont P; Zangerle PF
    Eur J Cancer (1965); 1977 Jul; 13(7):637-46. PubMed ID: 74336
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differentiation antigens in tumors: dependence on carcinogenesis mechanisms and progression (a hypothesis)].
    Abelev GI
    Mol Biol (Mosk); 2003; 37(1):4-11. PubMed ID: 12624942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some immunobiochemical approaches for the detection of metastases.
    Neville AM
    Invasion Metastasis; 1982; 2(1):2-11. PubMed ID: 6203866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biochemical characteristics of tumors in the central nervous system].
    Takakura K
    No To Shinkei; 1984 Apr; 36(4):307-16. PubMed ID: 6204664
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radioimmunoassays in oncology].
    Dressler J
    Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic criteria for the tumor markers of the body fluids].
    Konishi K; Nakagawa S; Watanabe K; Takamura S
    Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated carcinoembryonic antigen (CEA) levels in a patient with no malignancy.
    Shapiro M; Scapa E
    Hepatogastroenterology; 2000; 47(31):163-4. PubMed ID: 10690602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers].
    Cohen AD; Cohen Y
    Harefuah; 1993 Oct; 125(7-8):243-6. PubMed ID: 7693557
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tumor markers in the diagnosis of lung cancer].
    Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
    Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.